Overall rank by patents
#23,904
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
According to USPTO PatentsView, Arx ranks #23,904 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R23904 · US Corporation #23,904 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Argen-x N.v. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Arx · this assignee
46 score
Interactive Solutions · near
46 score
Klatu Networks · near
46 score
Openstream · near
46 score
Pacira Cryotech · near
46 score
3D Lighting Innovati… · lowest
7 score
What this shows Arx's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Arx, Llc is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2020. By volume, Arx sits between Argen-x N.v. and Aspargo Laboratories, Inc..
Arx, Llc shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ARGEN-X N.V.
11 patents
ARIA SOLUTIONS, INC.
11 patents
ARJOWIGGINS SECURITY
11 patents
ARKIS BIOSCIENCES INC.
11 patents
ASCENTIA IMAGING, INC.
11 patents
ASIA SATELLITE TELECOMMUNICATIONS COMPANY LIMITED
11 patents
ASO LLC
11 patents
ASPARGO LABORATORIES, INC.
11 patents
ARx, LLC
11 patents
What this shows Arx holds 11 patents at rank #23,832, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,832 in granted patent volume.
Other assignees with the most granted patents in Arx's primary technology class.
Two PlainPatent-derived peer sets for Arx, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (46 here).
Arx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 4 | 36.4% |
| 2020 | 1 | 9.1% |
| 2022 | 3 | 27.3% |
| 2023 | 2 | 18.2% |
| 2025partial year | 1 | 9.1% |
Top 2 of 2 technology areas
Overall rank by patents
#23,904
of 50,000 tracked assignees
46.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.